About ASH Clinical News

ASH Clinical News is your source for worldwide news and perspectives on hematology/oncology.

ASH Clinical News is a new magazine for American Society of Hematology members and non-members alike – offering news and views for the broader hematology/oncology community.

Each month, under the leadership of editor-in-chief, Mikkael Sekeres, MD, MS, Director of the Leukemia Program at the Cleveland Clinic, ASH Clinical News will provide you with the latest updates in the field – from on-site conference reporting, to the latest trials published in Blood, to policy issues affecting the science and practice of hematology – as well as perspectives and opinions from key leaders.

The publication will also provide tools and resources to help clinicians with quality and performance improvement, patient education, and the economics of running a practice.

Editorial Board

EDITOR-IN-CHIEF
Mikkael Sekeres, MD, MS
Vice-Chair for Clinical Research
Director, Leukemia Program
Cleveland Clinic, Taussig Cancer Institute

Cleveland, OH

ASSOCIATE EDITORS
Beth Faiman, CNP, PhD
Cleveland Clinic
Cleveland, OH

Alice Ma, MD
University of North Carolina School of Medicine
Chapel Hill, NC

David Steensma, MD
Dana-Farber Cancer Institute
Boston, MA

Keith Stewart, MBChB, MBA
Mayo Clinic
Scottsdale, AZ

All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036.

Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is assumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise or from any use or operation of any methods, products, instructions or ideas contained in the material herein.

Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer.

Advertisement

Current Issue

July 2017, Volume 3, Issue 8

This issue features an interview with the FDA's Richard Pazdur, highlights from the 2017 ASCO Annual Meeting, a debate about minimal residual disease in myeloma, and more.